CLINICAL_TRIALS
trial_result
· 2014-12-19
Clinical Trial Update: Remifentanil Intravenous Patient Controlled Analgesia (IVPCA) for Ablation of Idiopathic Ventricular Tachycardia [Phase 4]
Summary
Phase 4 trial update on remifentanil IVPCA for ablation of idiopathic ventricular tachycardia; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NYU Langone Health | Conditions: Tachycardia, Ventricular | Phase 4 | Status: COMPLETED | Results posted: 2014-12-19